These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7042558)

  • 1. Effect of BM 12531 on rosette formation and in vitro functions of peripheral blood lymphocytes obtained from healthy donors and cancer patients.
    Advani SH; Ghogale SR; Gangal SG
    Indian J Med Res; 1981 Nov; 74():705-14. PubMed ID: 7042558
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of BM 12 531 on in vitro induction of suppressor cells by concanavalin A in cancer patients and normal healthy donors.
    Somasundaram R; Advani SH; Shetye MR; Gangal SG
    J Clin Lab Immunol; 1986 Jan; 19(1):43-7. PubMed ID: 2939248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T- and B-lymphocytes of the peripheral blood in myeloma disease].
    Loginskiĭ VE; Kotsaĭ BR; Korotkiĭ VV
    Vrach Delo; 1978 Sep; (9):19-22. PubMed ID: 81566
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentration of rosette-forming cells and functional activity of peripheral blood T-lymphocytes in patients with different stages of lymphogranulomatosis].
    Loseva MI; Fridliand DIu
    Ter Arkh; 1981; 53(9):68-71. PubMed ID: 6975503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the immunological indices of the peripheral blood and lymph nodes in lymphogranulomatosis in children].
    Voĭtenkov BO; Gavrilenkova LP
    Vopr Onkol; 1985; 31(7):83-7. PubMed ID: 3875182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the immune modulators BM 12.531 (azimexone) and BM 41.332 on the subsets of T-lymphocytes in mice.
    Olsson L; Bicker U
    J Immunopharmacol; 1981-1982; 3(3-4):277-88. PubMed ID: 6215448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
    Puppo F; Corsini G; Mangini P; Armani U; Piana A
    Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
    [No Abstract]   [Full Text] [Related]  

  • 9. Total and 'active' E-rosette forming T lymphocytes in case of lymphoma: a preliminary communication.
    Kumar R; Sharma VK; Goel S; Mehrotra ML; Nagar AM
    Indian J Cancer; 1986 Sep; 23(3):185-91. PubMed ID: 3497863
    [No Abstract]   [Full Text] [Related]  

  • 10. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surface phenotype and suppressor function of the blood lymphocytes in multiple myeloma].
    Evsev'eva AI; Abramenko IV
    Eksp Onkol; 1984; 6(6):67-8. PubMed ID: 6241145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 14. [T cell biology studied using monoclonal antibodies. II. Functional characteristics of human T cell subpopulations in the peripheral blood].
    Rupniewska ZM
    Przegl Lek; 1984; 41(10):621-5. PubMed ID: 6400212
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of E rosette forming activity of human lymphocytes by rosette inhibiting factor (RIF) ann rosette restoring factor (RRF).
    Skibiński G; Zwoliński J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):475-80. PubMed ID: 117784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effect of paraproteinemic sera on the capacity of normal lymphocytes for rosette E formation].
    Soldà AM; Barabino A; Franceschini R; Mavilio R; Indiveri F
    Boll Soc Ital Biol Sper; 1977 Apr; 53(7):526-30. PubMed ID: 303111
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of BM 12,531 (azimexon) on in vitro lymphocyte and macrophage proliferation.
    Hadden JW; Coffey RG
    Recent Results Cancer Res; 1980; 75():162-4. PubMed ID: 7232828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of human red blood cells in lymphogranulomatosis by the H-rosette formation test].
    Pecze K; Telek B; Rák K
    Orv Hetil; 1984 Apr; 125(16):935-7. PubMed ID: 6609331
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation in vitro of immune parameters in homosexual males with the preclinical complex of symptoms related to acquired immune deficiency syndrome by azimexon.
    Patt YZ; Mavligit GM; Reuben J; Mansell PW; Li S; Newell G; Talpaz M; Hersh EM
    J Biol Response Mod; 1986 Jun; 5(3):263-9. PubMed ID: 3088215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.